CGRP receptor antagonists

Details for Australian Patent Application No. 2005295855 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Paone, Daniel V.; Potteiger, Craig M.; Shaw, Anthony W.

Agent Spruson & Ferguson

Pub. Number AU-B-2005295855

PCT Pub. Number WO2006/044449

Priority 60/618,715 14.10.04 US

Filing date 12 October 2005

Wipo publication date 27 April 2006

Acceptance publication date 18 August 2011

International Classifications

C07D 401/00 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 487/00 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/044449 Priority application(s): WO2006/044449

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

18 August 2011 Application Accepted

  Published as AU-B-2005295855

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005295859-Analogs of 17-hydroxywortmannin as PI3K inhibitors

2005295837-Binder composition comprising condensed tannin and furfuryl alcohol and its uses